South African phase 1 trial tests donor-line NK cells in relapsed B-cell lymphoma

A phase 1 trial in South Africa is testing engineered natural killer (NK) cells, grown from an established laboratory cell line, in patients with relapsed or treatment-resistant B-cell non-Hodgkin lymphoma. The study, QUILT-106, involves a team led at Wits Donald Gordon Medical Center by haematologist Dr Jackie Thom…